Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 132,040 | 88,820 | 60,130 | 47,660 | -147,660 |
| Depreciation Amortization | 170,840 | 159,790 | 127,280 | 91,050 | 289,150 |
| Other Working Capital | 40,420 | 16,650 | 180 | -13,170 | 6,900 |
| Other Operating Activity | -33,960 | -12,540 | -19,540 | -1,980 | -25,320 |
| Operating Cash Flow | $309,340 | $252,720 | $168,050 | $123,560 | $123,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71,750 | -37,720 | -29,450 | -53,330 | 11,630 |
| Net Acquisitions | -647,170 | -520,770 | -422,780 | 0 | 14,590 |
| Other Investing Activity | 561,280 | -130,980 | -56,140 | -333,580 | -198,910 |
| Investing Cash Flow | $-157,640 | $-689,470 | $-508,370 | $-386,910 | $-172,690 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 104,880 | 232,870 | 364,170 | -92,900 | 518,010 |
| Financing Cash Flow | $104,880 | $232,870 | $364,170 | $-92,900 | $518,010 |
| Exchange Rate Effect | -19,750 | 5,260 | 27,000 | 15,860 | -9,070 |
| Beginning Cash Position | 198,390 | 397,010 | 537,810 | 878,210 | 418,890 |
| End Cash Position | 435,230 | 198,390 | 588,670 | 537,810 | 878,210 |
| Net Cash Flow | $236,830 | $-198,610 | $50,860 | $-340,390 | $459,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | 309,340 | 252,720 | 168,050 | 123,560 | 123,070 |
| Free Cash Flow | 309,340 | 252,720 | 168,050 | 123,560 | 123,070 |